Methyl Parahydroxybenzoate (Nipagin) clinical trials

CMV preemptive therapy in high-risk immunocompetent major heart surgery patients. A multicenter, double blind, randomized, clinical trial (GAN-CAR).

This study looks at preventing serious infections in people having major heart surgery. It tests if certain medicines can stop a common virus called CMV from causing problems after the operation, helping patients recover better.